Media coverage and biotechnology IPOs: some Australian evidence

This paper analyses Australian biotechnology initial public offerings and the role of media coverage during the issue period in explaining capital raising, sentiment and underpricing. This paper finds empirical support for the hypothesis that an issuing company that receives more press coverage during the listing process leaves signifi cantly more money on the table than those who receive less coverage, a finding consistent with the presence of sentiment effects and hot issue periods